# Assessment of Body, Liver and Labile Plasma Iron and Their Association With Outcome and Immunological Recovery in Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Stem Cell Transplantation - ALLIVE (ALLogeneic Iron inVEstigators) Observational Trial

> **NCT01746147** · — · COMPLETED · sponsor: **GWT-TUD GmbH** · enrollment: 134 (actual)

## Conditions studied

- MDS and AML Prior to Allogeneic SCT

## Interventions

- **OTHER:** No intervention and study treatment

## Key facts

- **NCT ID:** NCT01746147
- **Lead sponsor:** GWT-TUD GmbH
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2015-12
- **Final completion:** 2016-12
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2016-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01746147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01746147, "Assessment of Body, Liver and Labile Plasma Iron and Their Association With Outcome and Immunological Recovery in Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Stem Cell Transplantation - ALLIVE (ALLogeneic Iron inVEstigators) Observational Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01746147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*